Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Morales

Showing results (731-740 of 739) with videos related to

Pageof 74
Sort By:
You have reached the last page of results.This site can display upto 739 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2021
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and SpainElena Roel, Andrea Pistillo, Martina Recalde, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudyRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network studyEdward Burn, Seng Chan You, Anthony Sena, et al.
Eclinicalmedicine|April 10, 2023
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyErica A Voss, Azza Shoaibi, Lana Yin Hui Lai, et al.
The Lancet. Rheumatology|September 1, 2020
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Nature Communications|October 7, 2020
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network studyEdward Burn, Seng Chan You, Anthony G Sena, et al.
Frontiers in Pharmacology|May 30, 2023
An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the CaribbeanAimeé Salas-Hernández, Macarena Galleguillos, Matías Carrasco, et al.
Clinical Epidemiology|March 29, 2022
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDISKristin Kostka, Talita Duarte-Salles, Albert Prats-Uribe, et al.
The Journal of Frailty & Aging|November 25, 2016
MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy AgeingJ Bousquet, R Bourret, T Camuzat, et al.
Pageof 74

Showing results (731-740 of 739) with videos related to

Sort By:
Pageof 74
You have reached the last page of results.This site can display upto 739 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2021
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and SpainElena Roel, Andrea Pistillo, Martina Recalde, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudyRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network studyEdward Burn, Seng Chan You, Anthony Sena, et al.
Eclinicalmedicine|April 10, 2023
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyErica A Voss, Azza Shoaibi, Lana Yin Hui Lai, et al.
The Lancet. Rheumatology|September 1, 2020
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Nature Communications|October 7, 2020
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network studyEdward Burn, Seng Chan You, Anthony G Sena, et al.
Frontiers in Pharmacology|May 30, 2023
An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the CaribbeanAimeé Salas-Hernández, Macarena Galleguillos, Matías Carrasco, et al.
Clinical Epidemiology|March 29, 2022
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDISKristin Kostka, Talita Duarte-Salles, Albert Prats-Uribe, et al.
The Journal of Frailty & Aging|November 25, 2016
MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy AgeingJ Bousquet, R Bourret, T Camuzat, et al.
Pageof 74